INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← Nutrition & Adequacy / Health Desk

A 16-week plant-based trial: insulin resistance and body-size changes

A different Kahleova trial examined insulin resistance and its relationship with changes in BMI and visceral fat.

Whole-food ingredients prepared without added oil

Illustrative food image, not a photograph of the study intervention.

A different trial from the 2020 report

This 2018 randomized trial enrolled 75 overweight adults with no history of diabetes. Thirty-eight were assigned to a low-fat plant-based diet and 37 to make no dietary changes for 16 weeks. Its focus was beta-cell function and insulin resistance, giving it a different emphasis from a simple weight-loss comparison. The researchers assessed beta-cell function with a mathematical model at baseline and at the end of the intervention. The abstract reports relationships between changes in body mass index, visceral fat, and metabolic measures; it does not provide an average kilogram weight-loss result. That missing figure should not be filled in from another trial.

Kahleova H, Tura A, Hill M, Holubkov R et al.. Nutrients, 2018. PMID 29425120 · DOI

Two different metabolic measurements

Investigators used a standard meal test and calculated insulin secretory rate through C-peptide deconvolution. They also assessed fasting insulin resistance with the Homeostasis Model Assessment index, or HOMA-IR. Meal-stimulated insulin secretion increased more in the intervention group than in controls, with a group-by-time interaction P value below 0.001. HOMA-IR fell with a treatment effect of -1.0, a 95% confidence interval of -1.2 to -0.8, and an interaction P value of 0.004. These are modeled physiological outcomes over 16 weeks. They are not evidence that participants with established diabetes achieved remission, especially because the enrolled adults had no history of diabetes.

Kahleova H, Tura A, Hill M, Holubkov R et al.. Nutrients, 2018. PMID 29425120 · DOI

Where body size enters the result

Changes in HOMA-IR correlated with changes in body mass index, with r=0.34 and P=0.009, and with visceral fat volume, with r=0.42 and P=0.001. The visceral-fat association remained statistically significant after adjustment for changes in BMI, with r=0.41 and P=0.002. This links the trial's insulin-resistance finding to body-composition change without supplying a kilogram weight-loss estimate. It does not establish that visceral-fat change independently caused the metabolic improvement. Correlations between changes, even within a randomized trial, are different from randomizing participants to lose a specified amount of visceral fat. The result is a mechanistic clue, not a precise weight-loss forecast.

Kahleova H, Tura A, Hill M, Holubkov R et al.. Nutrients, 2018. PMID 29425120 · DOI

Promising markers, bounded conclusions

Changes in glucose-induced insulin secretion correlated negatively with BMI changes, with r=-0.25 and P=0.04, but not with changes in visceral fat. The authors concluded that beta-cell function and insulin sensitivity improved with the low-fat plant-based intervention. The study was small and lasted 16 weeks, and the abstract does not report diabetes incidence or long-term weight maintenance. Its conflict statement also notes that Kahleova worked for an organization promoting low-fat plant-based diets, while Barnard had related organizational roles, book royalties, and lecture honoraria. Those disclosures belong alongside, not instead of, the randomized results. The trial supports short-term metabolic findings without settling long-term clinical outcomes.

Kahleova H, Tura A, Hill M, Holubkov R et al.. Nutrients, 2018. PMID 29425120 · DOI